Journal of General Internal Medicine

, Volume 22, Issue 6, pp 749–754 | Cite as

Decreased Awareness of Current Smoking Among Health Care Providers of HIV-positive Compared to HIV-negative Veterans

  • Kristina Crothers
  • Joseph L. Goulet
  • Maria C. Rodriguez-Barradas
  • Cynthia L. Gibert
  • Adeel A. Butt
  • R. Scott Braithwaite
  • Robin Peck
  • Amy C. Justice
Original Article

Abstract

BACKGROUND

Cigarette smoking is an important risk factor for morbidity and mortality in HIV-positive patients on combination antiretroviral therapy.

OBJECTIVE

To determine whether awareness of smoking differs between HIV and non-HIV providers, and to identify factors associated with failure to recognize current smoking.

DESIGN

Observational study.

PARTICIPANTS

801 HIV-positive and 602 HIV-negative patients, 72 HIV and 71 non-HIV providers enrolled in the Veterans Aging Cohort 5 Site Study.

MEASUREMENTS

Data sources included patient and provider questionnaires; electronic medical records; and the national administrative VA database. We calculated sensitivity, specificity, and measures of agreement between patient- and provider-reported smoking, and examined factors associated with failure to recognize current smoking using logistic regression.

RESULTS

Whereas most providers were correct when they identified a patient as a current smoker (specificity ≥90%), HIV providers missed current smoking more often (sensitivity 65% for HIV vs. 82% for non-HIV). Kappa scores for current smoking were significantly lower for HIV compared to non-HIV providers (0.55 vs. 0.75, p < .001). In models adjusted for age, gender, race, and other differences, patient HIV status and provider specialty in infectious diseases were independent predictors of a provider’s failure to recognize current smoking. Comorbid illnesses, cough/dyspnea, degree of immune competence and HIV viral suppression did not impact recognition of current smoking. Only 39% of HIV providers reported confidence in their ability to influence smoking cessation compared to 62% of non-HIV providers (p = .049).

CONCLUSIONS

Interventions to increase HIV provider awareness of current smoking and skills to influence smoking cessation are needed. Efforts should also target patient populations with smoking-related comorbid diseases who would especially benefit from smoking cessation.

KEY WORDS

tobacco detection of smoking HIV smoking cessation 

Notes

Acknkowledgments

This study was funded by: National Institutes of Health/National Center for Research Resources (K12 RR0117594-01) (KC); National Institute on Drug Abuse (K23 DA016175-01A1) (AAB); National Institute on Alcohol Abuse and Alcoholism (3U01 AA 13566), National Institute on Aging (K23 G00826), Robert Wood Johnson Generalist Faculty Scholar Award, the VHA Office of Research and Development, VHA Public Health Strategic Health Care Group, and an Inter-Agency Agreement between National Institute on Aging, National Institute of Mental Health, and the Veterans Health Administration (ACJ).

Conflicts of Interest

None disclosed.

References

  1. 1.
    Patel N, Talwar A, Reichert VC, Brady T, Jain M, Kaplan MH. Tobacco and HIV. Clin Occup Environ Med. 2006;5(1):193–207, xi.PubMedGoogle Scholar
  2. 2.
    Burns DN, Hillman D, Neaton JD, et al. Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(4):374–83.PubMedGoogle Scholar
  3. 3.
    Niaura R, Shadel WG, Morrow K, Tashima K, Flanigan T, Abrams DB. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis. 2000;31(3):808–12.PubMedCrossRefGoogle Scholar
  4. 4.
    Mamary EM, Bahrs D, Martinez S. Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDS. 2002;16(1):39–42.PubMedCrossRefGoogle Scholar
  5. 5.
    Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res. 2005;7(4):511–22.PubMedCrossRefGoogle Scholar
  6. 6.
    Benard A, Tessier JF, Rambeloarisoa J, et al. HIV infection and tobacco smoking behaviour: prospects for prevention? ANRS CO3 Aquitaine Cohort, 2002. Int J Tuberc Lung Dis. 2006;10(4):378–83.PubMedGoogle Scholar
  7. 7.
    Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003;362(9387):847–52.PubMedCrossRefGoogle Scholar
  8. 8.
    Crothers K, Griffith TA, McGinnis KA, et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med. 2005;20(12):1142–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Feldman JG, Minkoff H, Schneider MF, et al. Association of cigarette smoking with HIV prognosis among women in the HAART Era: a report from the Women’s Interagency HIV Study. Am J Public Health. 2006;96(6):1060–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med. 1995;333(13):845–51.PubMedCrossRefGoogle Scholar
  11. 11.
    Kohli R, Lo Y, Homel P, et al. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis. 2006;43(1):90–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Diaz PT, King MA, Pacht ER, et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med. 2000;132(5):369–72.PubMedGoogle Scholar
  13. 13.
    Crothers K, Butt AA, Gibert CL, Rodriguez-Barradas MC, Crystal S, Justice AC. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest. 2006;130(5):1326–33.PubMedCrossRefGoogle Scholar
  14. 14.
    Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285(13):1736–45.PubMedCrossRefGoogle Scholar
  15. 15.
    Miguez-Burbano MJ, Burbano X, Ashkin D, et al. Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy. Addict Biol. 2003;8(1):39–43.PubMedCrossRefGoogle Scholar
  16. 16.
    Sudano I, Spieker LE, Noll G, Corti R, Weber R, Luscher TF. Cardiovascular disease in HIV infection. Am Heart J. 2006;151(6):1147–55.PubMedCrossRefGoogle Scholar
  17. 17.
    Justice AC, Dombrowski E, Conigliaro J, et al. Veterans Aging Cohort Study (VACS): overview and description. Med Care. 2006;44(8 Suppl 2):S13–24.PubMedCrossRefGoogle Scholar
  18. 18.
    Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84(7):1086–93.PubMedCrossRefGoogle Scholar
  19. 19.
    Justice AC, Holmes W, Gifford AL, et al. Development and validation of a self-completed HIV symptom index. J Clin Epidemiol. 2001;54(Suppl 1):S77–90.PubMedCrossRefGoogle Scholar
  20. 20.
    Justice AC, Lasky E, McGinnis KA, et al. Medical disease and alcohol use among veterans with human immunodeficiency infection: a comparison of disease measurement strategies. Med Care. 2006;44(8 Suppl 2):S52–60.PubMedCrossRefGoogle Scholar
  21. 21.
    Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York: John Wiley and Sons; 1981.Google Scholar
  22. 22.
    Palella FJ, Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853–60.PubMedCrossRefGoogle Scholar
  23. 23.
    Crum NF, Riffenburgh RH, Wegner S, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41(2):194–200.PubMedCrossRefGoogle Scholar
  24. 24.
    Lewden C, Salmon D, Morlat P, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005;34(1):121–30.PubMedCrossRefGoogle Scholar
  25. 25.
    Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med. 2005;6(2):99–106.PubMedCrossRefGoogle Scholar
  26. 26.
    Braithwaite RS, Justice AC, Chang CC, et al. Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med. 2005;118(8):890–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Cummins D, Trotter G, Moussa M, Turham G. Smoking cessation for clients who are HIV-positive. Nurs Stand. 2005;20(12):41–7.PubMedGoogle Scholar
  28. 28.
    Vidrine DJ, Arduino RC, Lazev AB, Gritz ER. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS. 2006;20(2):253–60.PubMedCrossRefGoogle Scholar
  29. 29.
    Wewers ME, Neidig JL, Kihm KE. The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. J Assoc Nurses AIDS Care. 2000;11(6):37–44.PubMedCrossRefGoogle Scholar
  30. 30.
    An LC, Zhu SH, Nelson DB, et al. Benefits of telephone care over primary care for smoking cessation: a randomized trial. Arch Intern Med. 2006;166(5):536–42.PubMedCrossRefGoogle Scholar
  31. 31.
    Fultz SL, Goulet JL, Weissman S, et al. Differences between infectious diseases-certified physicians and general medicine-certified physicians in the level of comfort with providing primary care to patients. Clin Infect Dis. 2005;41(5):738–43.PubMedCrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2007

Authors and Affiliations

  • Kristina Crothers
    • 1
  • Joseph L. Goulet
    • 2
  • Maria C. Rodriguez-Barradas
    • 3
  • Cynthia L. Gibert
    • 4
  • Adeel A. Butt
    • 5
  • R. Scott Braithwaite
    • 2
  • Robin Peck
    • 4
  • Amy C. Justice
    • 2
  1. 1.Pulmonary and Critical Care Medicine, Department of Internal MedicineYale University School of MedicineNew HavenUSA
  2. 2.VA Connecticut Healthcare System, West Haven, and General Internal Medicine, Department of Internal MedicineYale University School of MedicineNew HavenUSA
  3. 3.Medical Service, Infectious DiseasesMichael A. DeBakey VA Medical Center, and Baylor College of MedicineHoustonUSA
  4. 4.Medical Service, Infectious DiseasesVA Medical Center, and George Washington UniversityWashingtonUSA
  5. 5.Infectious Diseases, Department of Internal MedicineVA Pittsburgh Healthcare System and University of Pittsburgh School of MedicinePittsburghUSA

Personalised recommendations